Trial intelligence / Profile preview

Custodiol-N vs Custodiol in Organ Transplantation

NCT03627013Phase 3Recruiting

Sponsor
Franz Köhler Chemie
Start
May 2019
Primary completion
Sep 2028
Modality
Device-based Delivery
Countries
1
01

Overview

A Phase 3 trial of histidine-tryptophan-ketoglutarate solution (modified) in kidney failure (ESRD), liver failure, sponsored by Franz Köhler Chemie. Started May 2019; status: recruiting.

02

Drugs

histidine-tryptophan-ketoglutarate solution (modified)
03

Conditions

kidney failure (ESRD)liver failure

Beyond the preview

Go deeper on NCT03627013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03627013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call